166 related articles for article (PubMed ID: 24354589)
1. Contrasting host immuno-inflammatory responses to bacterial challenge within venous and diabetic ulcers.
McInnes RL; Cullen BM; Hill KE; Price PE; Harding KG; Thomas DW; Stephens P; Moseley R
Wound Repair Regen; 2014; 22(1):58-69. PubMed ID: 24354589
[TBL] [Abstract][Full Text] [Related]
2. S100A8/A9 is an important host defence mediator in neuropathic foot ulcers in patients with type 2 diabetes mellitus.
Trøstrup H; Holstein P; Christophersen L; Jørgensen B; Karlsmark T; Høiby N; Moser C; Ågren MS
Arch Dermatol Res; 2016 Jul; 308(5):347-55. PubMed ID: 27084691
[TBL] [Abstract][Full Text] [Related]
3. The relationship between cytokine concentrations and wound healing in chronic venous ulceration.
Gohel MS; Windhaber RA; Tarlton JF; Whyman MR; Poskitt KR
J Vasc Surg; 2008 Nov; 48(5):1272-7. PubMed ID: 18771884
[TBL] [Abstract][Full Text] [Related]
4. Bacteriology, inflammation, and healing: a study of nanocrystalline silver dressings in chronic venous leg ulcers.
Sibbald RG; Contreras-Ruiz J; Coutts P; Fierheller M; Rothman A; Woo K
Adv Skin Wound Care; 2007 Oct; 20(10):549-58. PubMed ID: 17906429
[TBL] [Abstract][Full Text] [Related]
5. Wound bioburden and infection-related complications in diabetic foot ulcers.
Gardner SE; Frantz RA
Biol Res Nurs; 2008 Jul; 10(1):44-53. PubMed ID: 18647759
[TBL] [Abstract][Full Text] [Related]
6. Bacterial population of chronic crural ulcers: is there a difference between the diabetic, the venous, and the arterial ulcer?
Schmidt K; Debus ES; St Jessberger ; Ziegler U; Thiede A
Vasa; 2000 Feb; 29(1):62-70. PubMed ID: 10731891
[TBL] [Abstract][Full Text] [Related]
7. Serial surgical debridement: a retrospective study on clinical outcomes in chronic lower extremity wounds.
Cardinal M; Eisenbud DE; Armstrong DG; Zelen C; Driver V; Attinger C; Phillips T; Harding K
Wound Repair Regen; 2009; 17(3):306-11. PubMed ID: 19660037
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of TLR9 associated with pro-inflammatory S100A8 and IL-8 in diabetic wounds could lead to unresolved inflammation in type 2 diabetes mellitus (T2DM) cases with impaired wound healing.
Singh K; Agrawal NK; Gupta SK; Sinha P; Singh K
J Diabetes Complications; 2016; 30(1):99-108. PubMed ID: 26525587
[TBL] [Abstract][Full Text] [Related]
9. A prospective study of the microbiology of chronic venous leg ulcers to reevaluate the clinical predictive value of tissue biopsies and swabs.
Davies CE; Hill KE; Newcombe RG; Stephens P; Wilson MJ; Harding KG; Thomas DW
Wound Repair Regen; 2007; 15(1):17-22. PubMed ID: 17244315
[TBL] [Abstract][Full Text] [Related]
10. The role of surgical debridement in healing of diabetic foot ulcers.
Gordon KA; Lebrun EA; Tomic-Canic M; Kirsner RS
Skinmed; 2012; 10(1):24-6. PubMed ID: 22324173
[TBL] [Abstract][Full Text] [Related]
11. Non-healing is associated with persistent stimulation of the innate immune response in chronic venous leg ulcers.
Pukstad BS; Ryan L; Flo TH; Stenvik J; Moseley R; Harding K; Thomas DW; Espevik T
J Dermatol Sci; 2010 Aug; 59(2):115-22. PubMed ID: 20558044
[TBL] [Abstract][Full Text] [Related]
12. An observational study protocol to explore loneliness and systemic inflammation in an older adult population with chronic venous leg ulcers.
Kelechi TJ; Muise-Helmericks RC; Theeke LA; Cole SW; Madisetti M; Mueller M; Prentice MA
BMC Geriatr; 2021 Feb; 21(1):118. PubMed ID: 33568107
[TBL] [Abstract][Full Text] [Related]
13. A retrospective clinical study of 188 consecutive patients to examine the effectiveness of a biologically active cryopreserved human skin allograft (TheraSkin®) on the treatment of diabetic foot ulcers and venous leg ulcers.
Landsman AS; Cook J; Cook E; Landsman AR; Garrett P; Yoon J; Kirkwood A; Desman E
Foot Ankle Spec; 2011 Feb; 4(1):29-41. PubMed ID: 21135263
[TBL] [Abstract][Full Text] [Related]
14. S100A8/A9 deficiency in nonhealing venous leg ulcers uncovered by multiplexed antibody microarray profiling.
Trøstrup H; Lundquist R; Christensen LH; Jorgensen LN; Karlsmark T; Haab BB; Agren MS
Br J Dermatol; 2011 Aug; 165(2):292-301. PubMed ID: 21517798
[TBL] [Abstract][Full Text] [Related]
15. High bacterial load in asymptomatic diabetic patients with neurotrophic ulcers retards wound healing after application of Dermagraft.
Browne AC; Vearncombe M; Sibbald RG
Ostomy Wound Manage; 2001 Oct; 47(10):44-9. PubMed ID: 11890078
[TBL] [Abstract][Full Text] [Related]
16. Risk factors and healing impact of multidrug-resistant bacteria in diabetic foot ulcers.
Richard JL; Sotto A; Jourdan N; Combescure C; Vannereau D; Rodier M; Lavigne JP;
Diabetes Metab; 2008 Sep; 34(4 Pt 1):363-9. PubMed ID: 18632297
[TBL] [Abstract][Full Text] [Related]
17. The influence of patient and wound variables on healing of venous leg ulcers in a randomized controlled trial of growth-arrested allogeneic keratinocytes and fibroblasts.
Lantis JC; Marston WA; Farber A; Kirsner RS; Zhang Y; Lee TD; Cargill DI; Slade HB
J Vasc Surg; 2013 Aug; 58(2):433-9. PubMed ID: 23588112
[TBL] [Abstract][Full Text] [Related]
18. Bacterial diversity and inflammatory response at first-time visit in younger and older individuals with diabetic foot infection (DFI).
Dörr S; Freier F; Schlecht M; Lobmann R
Acta Diabetol; 2021 Feb; 58(2):181-189. PubMed ID: 32944830
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of wound fluid biomarkers to determine healing in adults with venous leg ulcers: A prospective study.
Stacey MC; Phillips SA; Farrokhyar F; Swaine JM
Wound Repair Regen; 2019 Sep; 27(5):509-518. PubMed ID: 31020747
[TBL] [Abstract][Full Text] [Related]
20. Expression and Influence of Matrix Metalloproteinase-9/Tissue Inhibitor of Metalloproteinase-1 and Vascular Endothelial Growth Factor in Diabetic Foot Ulcers.
Li G; Zou X; Zhu Y; Zhang J; Zhou L; Wang D; Li B; Chen Z
Int J Low Extrem Wounds; 2017 Mar; 16(1):6-13. PubMed ID: 28682675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
